The aim of this work was to assess the association between expression of TGM2 in both tumour and stromal compartment in invasive hormone receptor positive and hormone receptor negative female breast cancer in a cohort of 2169 women with early invasive breast cancer. This evidence concerns the gene NR4A1 and invasive breast carcinoma.